2021 Vaccines For Adults (VFA)

Closed Solicitation Posted Apr 5, 2021

This opportunity was awarded. See its 6 award notices in the notice history.

Solicitation number: 75D301-21-R-71821
Agency: CDC Office of Acquisition Services Centers for Disease Control and Prevention, Department of Health and Human Services
Responses due: Apr 20, 2021, 12:00 PM ET
Set-aside: No set-aside

Opportunity facts

NAICS code: 325412 Pharmaceutical Preparation Manufacturing
PSC: 6505 Drugs And Biologicals
Place of performance: United States

Notice details come from SAM.gov. Updated Jul 7, 2021.

About this opportunity

Written by GovTribe AI · Jan 1, 2024

This solicitation seeks indefinite-delivery, indefinite-quantity contracts for the Centers for Disease Control and Prevention to purchase 13 standard adult vaccines. Vaccines must be manufactured under current FDA licensure with a minimum 12-month shelf life. Delivery within 15 business days of order receipt is required to destinations directed under performance period contracts from July 1, 2021 through June 30, 2022. Proposals are due by April 19, 2021, with inquiries accepted through April 12, 2021.

There is no set-aside designation. Vaccines procured include estimated quantities of hepatitis A, hepatitis B, hepatitis A/B combination, pneumococcal polysaccharide, tetanus/diphtheria toxoids, herpes zoster, tetanus/diphtheria/acellular pertussis, measles/mumps/rubella, meningococcal conjugate, human papillomavirus, varicella, pneumococcal conjugate, and serogroup B meningococcal, with minimum order sizes listed. Performance will occur throughout the United States to support up to 50 state health departments and large city immunization programs under Public Health Service Section 317(j).

Notice text

2 versions

As posted on SAM.gov.

Update #2 · Latest · Jul 7, 2021

The receipt date for proposals is hereby extended from April 19, 2021, at 12pm eastern to April 20, 2021, at 12pm eastern.

The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) requires the award of one or more indefinite-delivery, indefinite-quantity contracts for the purchase of the following adult vaccines, at the estimated quantities listed, manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration.

Hepatitis A adult vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 1,000,000 doses
Minimum: 100 doses

Hepatitis B adult vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 375,000 doses
Minimum: 100 doses

Hepatitis A & B combination adult vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $1.50 per dose
Maximum: 275,000 doses
Minimum: 100 doses

Pneumococcal Polysaccharide vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: N/A
Maximum: 500,000 doses
Minimum: 100 doses

Tetanus and Diphtheria Toxoids vaccine for adults
Min. Shelf Life: 12 Months
Fed. Excise Tax: $1.50 per dose
Maximum: 100,000 doses
Minimum: 100 doses

Herpes Zoster vaccine for adults
Min. Shelf Life: 12 Months
Fed. Excise Tax: N/A
Maximum: 500,000 doses
Minimum: 100 doses

Tetanus, Reduced Diphtheria Toxoid, and Acellular Pertussis (TDaP) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $2.25 per dose
Maximum: 850,000 doses
Minimum: 100 doses

Measles, Mumps, and Rubella vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $2.25 per dose
Maximum: 250,000 doses
Minimum: 100 doses

Meningococcal Conjugate (Groups A,C,Y &W) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 200,000 doses
Minimum: 100 doses

Human Papillomavirus (HPV9) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 300,000 doses
Minimum: 100 doses

Varicella vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 150,000 doses
Minimum: 10 doses

Pneumococcal Conjugate (PCV13) vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 500,000 doses
Minimum: 100 doses

Serogroup B Meningococcal vaccine
Min. Shelf Life: 12 Months
Fed. Excise Tax: $0.75 per dose
Maximum: 200,000 doses
Minimum: 100 doses

All vaccines are required to be delivered within 15 business days after receipt of order. Vaccines shall be shipped F.O.B. destination, as directed by delivery orders. The period of performance shall be July 1, 2021 through June 30, 2022.

The vaccines awarded under these contracts will be purchased for NCIRD's immunization awardees (the fifty state health departments, several large city programs, and current and former U.S. Territories) to support adult immunization programs as provided under Section 317(j) of the Public Health Service Act.

This acquisition is being conducted in accordance with FAR Part 12 and Part 15 procedures. Please find the solicitation attached to this notice.

Offers shall be submitted by 12:00 pm Eastern Standard Time (EST) on April 19, 2021.

Any inquiries regarding this solicitation shall be submitted in writing to Joshua Houston at pkf5@cdc.gov and Pellumbeshe Hoxhaj at kfx2@cdc.gov no later than April 12, 2021 at 5:00 PM EST. Telephone inquiries will not be honored.

Update #1 · Apr 5, 2021